Value proposition

Next-generation regenerative medicine solutions, pioneering use of synthetic nanoclay gels for tissue regeneration.

Renovos is a new regenerative medicine company capitalising on the decades of world-class stem cell and orthopaedic research from the University of Southampton.

Renovos is developing next-generation regenerative medicine solutions, based on a synthetic nanoclay gel technology platform, Renovite.

Renovos offers a complementary range of products and services to address the needs of researchers and clinicians, developing solutions for tissue healing that is quicker, safer and more cost-effective.

Regenerative Medicine, Biomaterials, Drug Delivery, Medical Devices, Pharmaceuticals, Stem Cells, Cell Based Assays, and Orthopaedics